124 related articles for article (PubMed ID: 10602423)
1. Characterisation of the differential response of normal and CML haemopoietic progenitor cells to macrophage inflammatory protein-1alpha.
Dürig J; Testa NG; Lord BI; Kasper C; Chang J; Telford N; Dexter TM; Heyworth CM
Leukemia; 1999 Dec; 13(12):2012-22. PubMed ID: 10602423
[TBL] [Abstract][Full Text] [Related]
2. Abl protein kinase abrogates the response of multipotent haemopoietic cells to the growth inhibitor macrophage inflammatory protein-1 alpha.
Wark G; Heyworth CM; Spooncer E; Czaplewski L; Francis JM; Dexter TM; Whetton AD
Oncogene; 1998 Mar; 16(10):1319-24. PubMed ID: 9546433
[TBL] [Abstract][Full Text] [Related]
3. MCP-1, not MIP-1alpha, is the endogenous chemokine that cooperates with TGF-beta to inhibit the cycling of primitive normal but not leukemic (CML) progenitors in long-term human marrow cultures.
Cashman JD; Eaves CJ; Sarris AH; Eaves AC
Blood; 1998 Oct; 92(7):2338-44. PubMed ID: 9746772
[TBL] [Abstract][Full Text] [Related]
4. Macrophage inflammatory protein-1 alpha receptors are present on cells enriched for CD34 expression from patients with chronic myeloid leukemia.
Chasty RC; Lucas GS; Owen-Lynch PJ; Pierce A; Whetton AD
Blood; 1995 Dec; 86(11):4270-7. PubMed ID: 7492787
[TBL] [Abstract][Full Text] [Related]
5. Macrophage-inflammatory protein-1alpha receptor expression on normal and chronic myeloid leukemia CD34+ cells.
Nicholls SE; Lucas G; Graham GJ; Russell NH; Mottram R; Whetton AD; Buckle AM
J Immunol; 1999 May; 162(10):6191-9. PubMed ID: 10229864
[TBL] [Abstract][Full Text] [Related]
6. Expression of macrophage inflammatory protein-1 receptors in human CD34(+) hematopoietic cells and their modulation by tumor necrosis factor-alpha and interferon-gamma.
Dürig J; de Wynter EA; Kasper C; Cross MA; Chang J; Testa NG; Heyworth CM
Blood; 1998 Nov; 92(9):3073-81. PubMed ID: 9787141
[TBL] [Abstract][Full Text] [Related]
7. Biological effects of stroma-derived factor-1 alpha on normal and CML CD34+ haemopoietic cells.
Dürig J; Rosenthal C; Elmaagacli A; Heyworth C; Halfmeyer K; Kasper C; Novotny J; Dührsen U
Leukemia; 2000 Sep; 14(9):1652-60. PubMed ID: 10995013
[TBL] [Abstract][Full Text] [Related]
8. Effect of the hemoregulatory peptide (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 and MIP-1alpha is reduced in bone marrow cultures from patients with chronic myeloid leukemia (CML).
Karlic H; Louda N; Pfeilstöcker M; Keil F; Lohninger A; Pittermann E; Paukovits J
Stem Cells; 2001; 19(4):321-8. PubMed ID: 11463952
[TBL] [Abstract][Full Text] [Related]
9. Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells.
Veena P; Cornetta K; Davidson A; Agüero B; McMahel J; Traycoff CM; Srour EF
Bone Marrow Transplant; 1997 Jun; 19(12):1213-21. PubMed ID: 9208115
[TBL] [Abstract][Full Text] [Related]
10. Differential response of CD34+ cells isolated from cord blood and bone marrow to MIP-1 alpha and the expression of MIP-1 alpha receptors on these immature cells.
de Wynter EA; Durig J; Cross MA; Heyworth CM; Testa NG
Stem Cells; 1998; 16(5):349-56. PubMed ID: 9766815
[TBL] [Abstract][Full Text] [Related]
11. Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein 1 alpha, an inhibitor of primitive normal hematopoietic cells.
Eaves CJ; Cashman JD; Wolpe SD; Eaves AC
Proc Natl Acad Sci U S A; 1993 Dec; 90(24):12015-9. PubMed ID: 8265663
[TBL] [Abstract][Full Text] [Related]
12. [Expressions of MIP-1alpha, MCP-1 and their receptors CCR-1, CCR-2 in chronic myeloid leukemia cells].
Wang WL; Shen T; Hui YR; Gu XC; Li RS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):433-6. PubMed ID: 16800914
[TBL] [Abstract][Full Text] [Related]
13. Macrophage inflammatory protein 1alpha enhances in a different manner adhesion of hematopoietic progenitor cells from bone marrow, cord blood, and mobilized peripheral blood.
Suehiro Y; Muta K; Umemura T; Abe Y; Nishimura J; Nawata H
Exp Hematol; 1999 Nov; 27(11):1637-45. PubMed ID: 10560911
[TBL] [Abstract][Full Text] [Related]
14. The tetrapeptide AcSDKP specifically blocks the cycling of primitive normal but not leukemic progenitors in long-term culture: evidence for an indirect mechanism.
Cashman JD; Eaves AC; Eaves CJ
Blood; 1994 Sep; 84(5):1534-42. PubMed ID: 8068944
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of immature erythroid progenitor cell proliferation by macrophage inflammatory protein-1alpha by interacting mainly with a C-C chemokine receptor, CCR1.
Su S; Mukaida N; Wang J; Zhang Y; Takami A; Nakao S; Matsushima K
Blood; 1997 Jul; 90(2):605-11. PubMed ID: 9226160
[TBL] [Abstract][Full Text] [Related]
16. Abnormal growth factor modulation of beta1-integrin-mediated adhesion in chronic myelogenous leukaemia haematopoietic progenitors.
Bhatia R; Munthe HA; Forman SJ
Br J Haematol; 2001 Dec; 115(4):845-53. PubMed ID: 11843818
[TBL] [Abstract][Full Text] [Related]
17. [Macrophage inflammatory protein-1α promotes the growth of acute myeloid leukemia cells].
Lu P; Wang YJ; Zheng YW; Dong F; Pang YK; Cheng H; Yuan WP; Cheng T; Hao S
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Apr; 23(2):306-11. PubMed ID: 25948176
[TBL] [Abstract][Full Text] [Related]
18. [Protection of hematopoietic stem cells by MIP-1alpha and PF4 against the cytotoxicity of chemotherapeutic agents].
Huang K; Huang S; Pan J; Wu Y
Zhonghua Xue Ye Xue Za Zhi; 2000 Jul; 21(7):355-8. PubMed ID: 11877004
[TBL] [Abstract][Full Text] [Related]
19. Contrasting effects of rh-MIP-1 alpha and TGF-beta 1 on chronic myeloid leukemia progenitors in vitro.
Holyoake TL; Freshney MG; Sproul AM; Richmond LJ; Alcorn MJ; Steward WP; Fitzsimons E; Dunlop DJ; Franklin IM; Pragnell IB
Stem Cells; 1993 Oct; 11 Suppl 3():122-8. PubMed ID: 8298472
[TBL] [Abstract][Full Text] [Related]
20. Macrophage inflammatory protein 1alpha attenuates the toxic effects of temozolomide in human bone marrow granulocyte-macrophage colony-forming cells.
Clemons M; Watson A; Howell A; Chang J; Heyworth C; Lord B; Testa N; Dexter TM; Margison G
Clin Cancer Res; 2000 Mar; 6(3):966-70. PubMed ID: 10741722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
